Stryker appoints a new head for its India operations

By Catherine Sturman
Leading medical technology company Stryker has revealed that it has appointed Meenakshi Nevatia as the company’s new managing director within its oper...

Leading medical technology company Stryker has revealed that it has appointed Meenakshi Nevatia as the company’s new managing director within its operations in India.

Asia is fast becoming one of the most promising markets. With an ageing population, increased pressures on healthcare organisations are leading health tech companies to view the area’s lucrative, long-term potential, particularly with the launch of its National Health Protection Scheme, Ayushman Bharat.

Responsible for driving the company’s business strategy, and extend the company’s footprint across the Indian market.

With extensive experience working for healthcare giant Novartis, Nevatia is well placed in tackling the challenges which entering a new market will bring to the business.

See also

"Customers and patients are at the heart of everything we do, and I look forward to bringing together our team to do more to improve lives in India," she said.

"I also look forward to creating an environment where our people, one of our core values, can continue to thrive and grow.”

Additionally, Nevatia has a Master in Business Administration in Strategy and Finance from the Indian Institute of Management, Ahmedabad, and Bachelor of Science in Economics and Mathematics from the Presidency College, Kolkata.

The news follows on from the company’s recent acquisition of HyperBranch Medical Technology, Inc., as part of its long-term growth strategy.

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability